Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

New drug delivery systems improve treatment effectiveness and patient experience.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

IL-17 and certain immune cells are linked to more severe alopecia areata.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

COVID-19 infection may trigger alopecia areata in some patients.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

A man with skin and hair symptoms improved partially with specific treatment.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Apremilast did not work for treating severe alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.